Trial Details

COMPLETED
Basic Information
Clinical ID c2237
Identifier NCT03806127
Trial Title Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Irritable Bowel Syndrome
Interventions DRUG: Vibegron|DRUG: Placebo
Participant Information
Sponsor Urovant Sciences GmbH
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-12-31
Primary Completion Date 2020-09-25
Completion Date 2020-10-06